Neuphoria TherapeuticsNEUP
13F holders, Q2 2025 (June 30)9holders +2
2new positions
0sold out
1famous investor
$7.10avg. 13F price*
At the end of Q2 2025, 9 institutions reported holding Neuphoria Therapeutics Inc. (NEUP) in their 13F filings, up 2 from Q1 2025. 2 opened new positions and 0 sold out. The largest holders were AdvisorShares Investments LLC ($481K), Lynx1 Capital Management LP ($325K) and Prosperity Wealth Management, Inc. ($211K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Neuphoria Therapeutics Inc.
- CUSIP
- 64136E102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $104K |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 17,157 shares bought and 2,308 shares sold, net +14,849 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| AdvisorShares Investments LLC | 0.09% | Reduce -2.8% | 67,733 | $481K |
| Lynx1 Capital Management LP | 0.09% | No change | 45,806 | $325K |
| Prosperity Wealth Management, Inc. | 0.08% | Add +9.4% | 29,750 | $211K |
| Citadel Advisors | 0.00% | New | 14,606 | $104K |
| Merck & Co., Inc. | 0.03% | No change | 10,027 | $71K |
| Cyndeo Wealth Partners, LLC | 0.00% | No change | 10,000 | $71K |
| Rhumbline Advisers | 0.00% | Reduce -92.0% | 33 | $234 |
| Morgan Stanley | 0.00% | No change | 7 | $50 |
| Bank of America Corp. | 0.00% | New | 1 | $7 |
"% of holder's portfolio" is NEUP's weight in each manager's 13F, not the share of Neuphoria Therapeutics Inc. the manager owns.